New drug candidate BI 770371 tested for MASH-Related cirrhosis

NCT ID NCT06675929

First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 26 times

Summary

This study tested the safety of an experimental drug called BI 770371 in 28 adults with compensated cirrhosis (liver scarring) due to MASH, a fatty liver disease. Participants received either the drug or a placebo as an IV infusion every 3 weeks for 12 weeks. The main goal was to see how well the drug was tolerated and to monitor any side effects. The study is now complete.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS(MASH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • American Research Corporation at the Texas Liver Institute

    San Antonio, Texas, 78215, United States

  • Blessed Health Care

    Miami, Florida, 33174-3245, United States

  • Catalina Research Institute, LLC-Montclair-49051

    Montclair, California, 91763, United States

  • Evolution Clinical Trials

    Miami, Florida, 33122, United States

  • Houston Research Institute

    Houston, Texas, 77079, United States

  • Inland Empire Clinical Trials, LLC

    Rialto, California, 92377, United States

  • Knowledge Research Center

    Orange, California, 92868, United States

  • Peak Gastroenterology Associates-Colorado Springs-67762

    Colorado Springs, Colorado, 80907, United States

  • Pinnacle Clinical Research, LLC

    San Antonio, Texas, 78229, United States

  • Progressive Medical Research

    Port Orange, Florida, 32127, United States

  • Southern California Research Center

    Coronado, California, 92118, United States

  • The Institute for Liver Health II dba Arizona Clinical Trials

    Chandler, Arizona, 85225, United States

  • The Liver Institute at Methodist Dallas

    Dallas, Texas, 75203, United States

Conditions

Explore the condition pages connected to this study.